Lynk Pharmaceuticals Doses First Patient in Phase III Trial for Atopic Dermatitis Treatment
Lynk Pharmaceuticals Co., Ltd, based in China, has announced the dosing of the first patient...
Company
HutchMed Launches Phase II/III Study for Sovleplenib in Autoimmune Hemolytic Anemia
HutchMed (China) Ltd (NASDAQ: HCM; HKG: 0013) has announced the initiation of the Phase II/III...
NeuExcell Therapeutics Doses First Patient in Groundbreaking Clinical Trial for NeuroD1 Gene Therapy
NeuExcell Therapeutics, a Shanghai-based developer of in vivo neural regenerative therapies, has announced the first...
Astra Biotech Raises Tens of Millions in Pre-Series B Funding to Expand Diagnostic Capabilities
Astra Biotech, a developer of single molecule immunodiagnostic technology based in Suzhou, has reportedly raised...
Horimed Secures Tens of Millions in Financing to Advance OCT Imaging Technologies
Horimed, a Tianjin-based manufacturer of OCT imaging equipment, has reportedly raised “tens of millions” of...
Beijing Varnotech Biopharm Secures RMB 600 Million in Series B Funding for Vaccine Development
Beijing Varnotech Biopharm Ltd, a China-based specialist in human vaccines, has successfully raised RMB 600...
PoreSpect Secures Tens of Millions in Angel Funding Led by Forcefield Ventures
PoreSpect, a Guangdong-based manufacturer of devices and consumables, has reportedly secured “tens of millions” of...
Intuitive Surgical’s Ion Robotic System Gains Regulatory Approval in China
Intuitive Surgical (NASDAQ: ISRG), a leading medical robotics firm based in the US, has announced...
Henlius Biotech Posts 67.8% YOY Revenue Growth and First Annual Profit in 2023 Financials
Shanghai Henlius Biotech Inc., (HKG: 2696) has released its financial results for 2023, reporting revenues...
Bayer Eliminates C-Level Roles in Restructuring Efforts to Boost Profitability
Germany’s Bayer (ETR: BAYN) has taken significant steps in its restructuring efforts by eliminating 8...
Baidu Health Partners with Yibang to Enhance Operations for Brick-and-Mortar Pharmacies
Baidu Health has entered into a strategic partnership with Shanghai Yibang Medicine Information Technology Co.,...
Edan Instruments Partners with Global Health Labs to Develop AI-Enhanced Handheld Ultrasound
Shenzhen-based Edan Instruments Inc. has forged a strategic partnership with Global Health Labs Inc. to...
FDA Grants Accelerated Approval for Takeda’s Iclusig in Newly Diagnosed Ph+ ALL
The U.S. Food and Drug Administration (FDA) has granted accelerated indication extension approval to Japan’s...
Simcere Pharmaceutical Reports 4.5% Revenue Growth in 2023 Amid Shifts in Profitability
Simcere Pharmaceutical Group (HKG: 2096), based in China, has released its 2023 financial performance report,...
Sinopharm and Fresenius Kabi Expand Partnership to Enhance Drug Distribution and Healthcare Services
China’s state-owned Sinopharm Group Co., Ltd. (HKG: 1099) has announced a new partnership with Germany’s...
Bayer and Thermo Fisher Partner to Develop Rapid Companion Diagnostics for Precision Oncology
Germany’s Bayer (NYSE: BAYE) has entered into a strategic partnership with U.S. life sciences leader...
iRegene’s NouvSight001 Gains Orphan Drug Designation for Retinitis Pigmentosa Treatment
Wuhan-based cell therapy innovator iRegene has secured Orphan Drug Designation (ODD) from the U.S. FDA...
BMS Reports Positive Phase III Results for Opdivo and Yervoy in Advanced HCC
Bristol Myers Squibb (BMS; NYSE: BMY) announced this week that its Phase III study evaluating...
China Resources Guangdong Pharmaceutical Partners with BD to Enhance Drug and Device Distribution in GBA
China Resources Guangdong Pharmaceutical Co., Ltd has entered into a strategic partnership with U.S.-based Becton,...
VIVA Biotech Secures Licensing Deal with Lonza for Advanced Bispecific Antibody Technology
VIVA Biotech Holdings (HKG: 1873), a China-based Contract Research Organization (CRO), has entered into a...